Kyoto, Japan

Seiichi Tanida


Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 823(Granted Patents)


Location History:

  • Nagaokakyo, JP (1981 - 1996)
  • Kyoto, JP (1979 - 1999)
  • Nagaokayo, JP (2004)

Company Filing History:


Years Active: 1979-2004

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Seiichi Tanida: Innovator in Heart Disease Therapeutics

Introduction

Seiichi Tanida, a notable inventor hailing from Kyoto, Japan, has made significant contributions to the field of pharmaceuticals, particularly in the realm of heart disease prevention and treatment. With a remarkable portfolio of 21 patents, Tanida's innovations have the potential to enhance therapeutic options for patients suffering from various cardiac conditions.

Latest Patents

One of Tanida's latest groundbreaking patents involves heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases. This invention centers around condensed thiazine derivatives, along with their production and applications. The specific compound covered in the patent features a formula defined by variations of groups that include hydrogen, carbon, nitrogen, and oxygen, demonstrating diverse binding properties. Remarkably, this compound exhibits Th1 and Th2 cell function modulating activity and shows promise as a therapeutic and prophylactic agent against allergic or autoimmune diseases, graft rejection, and graft-vs-host disease.

Career Highlights

Throughout his career, Seiichi Tanida has been associated with prestigious companies such as Takeda Chemical Industries, Inc. and Takeda Chemical Ind., Ltd. His work at these organizations has facilitated advancements in pharmaceutical research, specifically targeting heart disease treatments. Tanida’s commitment to innovation in medicine has earned him a prominent position in the industry.

Collaborations

Collaboration is vital in the field of innovation, and Tanida has worked alongside esteemed colleagues, including Mitsuko Asai and Eiji Higashide. These partnerships have allowed for a multidisciplinary approach to research and product development, enhancing the overall efficacy of their collective work.

Conclusion

Seiichi Tanida's contributions to heart disease therapeutics through his 21 patents signify a vital advancement in medical science. His work exemplifies the impact of innovation in addressing critical health challenges. With ongoing research and development, Tanida continues to inspire future inventors in the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…